Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion
Biomolecules · 21.03.2025 · 15 (4) · 458
DOI: 10.3390/biom15040458 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, online erschienen am 21.03.2025. Verfasst von Vishal Srivastava und 7 weiteren Autor:innen. Beteiligte Einrichtung: Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA. Hauptthemen laut MEDLINE: Factor VIII, Mutation, Missense, Hemophilia A, Proteostasis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Missense mutations are the most prevalent alterations in genetic disorders such as hemophilia A (HA), which results from coagulation factor VIII (FVIII) deficiencies. These mutations disrupt protein biosynthesis, folding, secretion, and function. Current treatments for HA are extremely expensive and inconvenient for patients. Small molecule drugs offer a promising alternative or adjunctive strategy due to their lower cost and ease of administration, enhancing accessibility and patient compliance. By screening drug/chemical libraries with cells stably expressing FVIII–Gaussia luciferase fusion proteins, we identified compounds that enhance FVIII secretion and activity. Among these, suberoylanilide hydroxamic acid (SAHA) improved the secretion and activity of wild-type FVIII and common HA-associated missense mutants, especially mild and moderate ones. SAHA increased FVIII interaction with the endoplasmic reticulum chaperone BiP/GRP78 but not with calreticulin. Lowering cellular BiP levels decreased SAHA-induced FVIII secretion and enhancing BiP expression increased FVIII secretion. SAHA also enhanced secretion and BiP interactions with individual domains of FVIII. In vivo, treating mice with SAHA or a BiP activator boosted endogenous FVIII activity. These findings suggest that SAHA serves as a proteostasis regulator, providing a novel therapeutic approach to improve the secretion and functionality of FVIII missense mutants prone to misfolding.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genomic Medicine Institute, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
- Research Centre for Infectious Diseases, Department of Molecular and Biomedical Science, University of Adelaide, Adelaide, SA 5005, Australia.
- Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
- Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH 44195, USA.
ORCID-Profile: Vishal Srivastava, Zhigang Liu, Bin Zhang
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
- Judith Graham Pool Postdoctoral Fellowship from the National Bleeding Disorders Foundation
Zitieren
APA
Srivastava, V., Liu, Z., Wei, W., Zhang, Y., Paton, J. C., Paton, A. W., Mu, T., & Zhang, B. (2025). Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion. Biomolecules, 15(4), 458. https://doi.org/10.3390/biom15040458
Vancouver
Srivastava V, Liu Z, Wei W, Zhang Y, Paton JC, Paton AW, et al. Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion. Biomolecules. 2025;15(4):458. doi:10.3390/biom15040458
BibTeX
@article{Srivastava2025,
author = {Srivastava, Vishal and Liu, Zhigang and Wei, Wei and Zhang, Yuan and Paton, James C and Paton, Adrienne W and Mu, Tingwei and Zhang, Bin},
title = {Cell-Based Small-Molecule Screening Identifying Proteostasis Regulators Enhancing Factor VIII Missense Mutant Secretion},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {4},
pages = {458},
doi = {10.3390/biom15040458}
}
EUVIMED